A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support (REMAP ECMO)
Cardiogenic Shock
About this trial
This is an interventional treatment trial for Cardiogenic Shock focused on measuring Left ventricular unloading, Venoarterial ExtraCorporeal Membrane Oxygenation (VA ECMO), Cardiogenic shock
Eligibility Criteria
Inclusion criteria for the registry backbone: Having received ECMO support for severe circulatory and/or respiratory insufficiency Inclusion Criteria for the LV unloading trial domain (VA ECMO + IABP vs VA ECMO alone): Cardiogenic shock Having received VA ECMO support for severe circulatory (and respiratory insufficiency). Age ≥ 18 years Initiation of LV unloading (IABP or Impella) possible ≤ 8 hours after ECMO initiation Exclusion criteria for the registry backbone Objection to participation in the registry by the patient and/or proxy VA ECMO usage confined to the period during surgery or another intervention (the VA ECMO was removed at the end of the intervention in the operation room). Exclusion criteria for the LV unloading trial domain (VA ECMO + IABP vs VA ECMO alone) No (deferred) informed consent provided by the patient and/or proxy. Pregnancy ECMO usage confined to the period during surgery or another intervention (the ECMO was removed at the end of the intervention). Isolated right ventricular failure (e.g. due to pulmonary embolism). Left ventricular assist device (LVAD), Impella or IABP in situ. Ventricular septal defect or papillary muscle rupture as the cause of shock. Thoracic or abdominal aortic dissection. Moderate or severe aortic regurgitation Mechanical prosthesis in mitral valve position
Sites / Locations
- Amphia hospital
- Catharina hospital
- Amsterdam University Medical Center
- Antonius hospital
- Haga ziekenhuis
- Leiden University Medical Center
- Erasmus Medical CenterRecruiting
- University Medical Center Utrecht
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
IABP unloading arm
ECMO alone arm
This group of patients will receive an intra-aortic balloon pump (IABP) as an adjunct to VA ECMO support. When allocated to the IABP unloading arm, patients must receive an IABP within 8 hours after VA ECMO initiation.
This group of patients will receive VA ECMO support without left ventricular unloading device after randomization.